Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912950 · ClinicalTrials.gov registry record · NA
Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair
A NA study of Hypertrichosis, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01912950 is a NA study of Hypertrichosis that has completed, run by Cutera. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01912950, a NA study of Hypertrichosis, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized, controlled, open-label pilot study is to evaluate the safety and efficacy of a novel intense pulsed light (IPL) device for removal of unwanted fine body hair. Subjects will have IPL treatment on one forearm area. Another area will serve as the un-treated control area. Subjects will be followed at 12-weeks post-final treatment.
Conditions Studied
Interventions
- DEVICE Prowave LX IPL
Study Locations (1)
New York
- Sadick Research Group - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01912950
The ClinicalTrials.gov registry entry for NCT01912950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertrichosis appearing as the primary indexed condition, and to 1 intervention - of which Prowave LX IPL is the first listed.
NCT01912950 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01912950 about?
NCT01912950 is a clinical study titled "Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair". The purpose of this randomized, controlled, open-label pilot study is to evaluate the safety and efficacy of a novel intense pulsed light (IPL) device for removal of unwanted fine body hair. Subjects will have IPL treatment on one forearm area. Another area will serve as the un-treated control area...
What is the current status of trial NCT01912950?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-12. Estimated completion is 2015-07.
What conditions does trial NCT01912950 study?
This clinical trial studies the following conditions: Hypertrichosis.
What interventions are being tested in trial NCT01912950?
The interventions under investigation include: Prowave LX IPL (DEVICE).
Who is sponsoring clinical trial NCT01912950?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01912950 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrichosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.